European Sleep Apnea and Sudden CArdiac Death ProjEct

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 900 participants.

Also called NCT02506166

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 900 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02506166
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02506166. Randomized; no masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2021-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
European Sleep Apnea and Sudden CArdiac Death ProjEct
Acronym
ESCAPE-SCD
Condition
Sleep Apnea
Condition
Sudden Cardiac Death
Condition
Heart Failure
Condition
Ischemic Cardiomyopathy
Intervention (Device)
Positive Airway Pressure Therapy
Lead sponsor
University Hospital Olomouc (class: other)
Collaborator
Mayo Clinic (class: other)

Record details

Record id
cardio:ct-nct02506166
Content hash
fb0297117760f9d4e245bda31d4be5de8919d1c0dc0daecc1cd2bd9eccff6df6